<DOC>
	<DOCNO>NCT02930447</DOCNO>
	<brief_summary>Autologous glue therapy platelet-rich plasma ( PRP ) report improve outcome plastic surgery . However , pilot study retrospective uncontrolled trial report potential benefit autologous glue treatment . Therefore , large , blind , randomize placebo-controlled clinical trial would useful determine whether platelet-rich plasma safe effective abdominoplasty procedure . Currently , pharmacological option artificial fibrin glue compose homologous fibrinogen animal-derived thrombin . However , therapeutic present risk transmissible disease may induce allergic reaction . Therefore , autologous glue , fully make blood component patient ( autologous fibrinogen contain PRP autologous thrombin ) represent safe alternative artificial biological glue . Regen Lab SA develop RegenKit速-Surgery prepare autologous PRP , one hand , autologous activate thrombin serum , hand , safe rapid manner . RegenKit速-Surgery CE-marked class IIb medical device . This study , conduct 56 patient , evaluate effect autologous glue prepare RegenKit速-Surgery use reconstructive abdominoplasty .</brief_summary>
	<brief_title>Evaluation Benefit Use Autologous Glue Prepared With RegenKit速-Surgery Device Abdominoplasty</brief_title>
	<detailed_description />
	<criteria>Patients 18 year age indication abdominoplasty Signature inform consent form Capable understanding study 's imperative Participation ongoing last two month another clinical trial Pregnancy breastfeed Autoimmune disease ( e.g . Hashimoto , rheumatoid arthritis , lupus , etc . ) Hereditary acquire hematologic disorder ( e.g . drepanocytosis , etc . ) Haemoglobin &lt; 10g/dl Haematocrit &lt; 33 % Hereditary acquire coagulation disorder ( e.g . platelet dysfunction syndrome , critical thrombocytopenia platelet count &lt; 150'000/microlitre , impaired coagulation , etc . ) Systemic disorder diabetes , hepatitis Acute infection Any active malignancy Chemotherapy Refusal incapacity give Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>